Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease.

MLA

Kim SW, et al. “Human Peripheral Blood-Derived CD31+ Cells Have Robust Angiogenic and Vasculogenic Properties and Are Effective for Treating Ischemic Vascular Disease.” Journal of the American College of Cardiology (JACC), vol. 56, no. 7, Aug. 2010, pp. 593–607. EBSCOhost, https://doi.org/10.1016/j.jacc.2010.01.070.

APA

Kim SW, Kim H, Cho HJ, Lee JU, Levit R, Yoon YS, Kim, S.-W., Kim, H., Cho, H.-J., Lee, J.-U., Levit, R., & Yoon, Y. (2010). Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. Journal of the American College of Cardiology (JACC), 56(7), 593–607. https://doi.org/10.1016/j.jacc.2010.01.070

Chicago

Kim SW, Kim H, Cho HJ, Lee JU, Levit R, Yoon YS, Sung-Whan Kim, et al. 2010. “Human Peripheral Blood-Derived CD31+ Cells Have Robust Angiogenic and Vasculogenic Properties and Are Effective for Treating Ischemic Vascular Disease.” Journal of the American College of Cardiology (JACC) 56 (7): 593–607. doi:10.1016/j.jacc.2010.01.070.